調査レポート | • レポートコード：GIR-2104Z04324 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥494,160 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥741,240 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥988,320 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、診断用バイオマーカーのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。診断用バイオマーカーの種類別市場規模（安全性バイオマーカー、有効性バイオマーカー、検証バイオマーカー）、用途別市場規模（病院、がん研究所、診断研究所）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・診断用バイオマーカーの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Qiagen N.V.、Perkinelmer, Inc.、Merck Millipore、Bio-Rad Laboratories, Inc.、Enzo Biochem, Inc.、EKF Diagnostics Holdings, Inc.、Meso Scale Diagnostics, LLC.、Biosims Technologies Sas、Cisbio Bioassays、Signosis, Inc、Banyan Biomarkers, Inc、Biomedical Corp ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：安全性バイオマーカー、有効性バイオマーカー、検証バイオマーカー ・用途別分析2016年-2026年：病院、がん研究所、診断研究所 ・診断用バイオマーカーの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・診断用バイオマーカーのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・診断用バイオマーカーのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・診断用バイオマーカーの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・診断用バイオマーカーの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Diagnostic Biomarkers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Diagnostic Biomarkers size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Diagnostic Biomarkers market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Diagnostic Biomarkers market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Safety Biomarkers
Efficacy Biomarkers
Validation Biomarkers
Market segment by Application, can be divided into
Hospitals
Cancer Research Institutes
Diagnostic Labs
Market segment by players, this report covers
Qiagen N.V.
Perkinelmer, Inc.
Merck Millipore
Bio-Rad Laboratories, Inc.
Enzo Biochem, Inc.
EKF Diagnostics Holdings, Inc.
Meso Scale Diagnostics, LLC.
Biosims Technologies Sas
Cisbio Bioassays
Signosis, Inc
Banyan Biomarkers, Inc
Biomedical Corp
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Diagnostic Biomarkers
1.2 Classification of Diagnostic Biomarkers by Type
1.2.1 Overview: Global Diagnostic Biomarkers Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Diagnostic Biomarkers Revenue Market Share by Type in 2020
1.2.3 Safety Biomarkers
1.2.4 Efficacy Biomarkers
1.2.5 Validation Biomarkers
1.3 Global Diagnostic Biomarkers Market by Application
1.3.1 Overview: Global Diagnostic Biomarkers Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Cancer Research Institutes
1.3.4 Diagnostic Labs
1.4 Global Diagnostic Biomarkers Market Size & Forecast
1.5 Global Diagnostic Biomarkers Market Size and Forecast by Region
1.5.1 Global Diagnostic Biomarkers Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Diagnostic Biomarkers Market Size by Region, (2016-2021)
1.5.3 North America Diagnostic Biomarkers Market Size and Prospect (2016-2026)
1.5.4 Europe Diagnostic Biomarkers Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Diagnostic Biomarkers Market Size and Prospect (2016-2026)
1.5.6 South America Diagnostic Biomarkers Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Diagnostic Biomarkers Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Diagnostic Biomarkers Market Drivers
1.6.2 Diagnostic Biomarkers Market Restraints
1.6.3 Diagnostic Biomarkers Trends Analysis
2 Company Profiles
2.1 Qiagen N.V.
2.1.1 Qiagen N.V. Details
2.1.2 Qiagen N.V. Major Business
2.1.3 Qiagen N.V. Diagnostic Biomarkers Product and Solutions
2.1.4 Qiagen N.V. Diagnostic Biomarkers Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Qiagen N.V. Recent Developments and Future Plans
2.2 Perkinelmer, Inc.
2.2.1 Perkinelmer, Inc. Details
2.2.2 Perkinelmer, Inc. Major Business
2.2.3 Perkinelmer, Inc. Diagnostic Biomarkers Product and Solutions
2.2.4 Perkinelmer, Inc. Diagnostic Biomarkers Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Perkinelmer, Inc. Recent Developments and Future Plans
2.3 Merck Millipore
2.3.1 Merck Millipore Details
2.3.2 Merck Millipore Major Business
2.3.3 Merck Millipore Diagnostic Biomarkers Product and Solutions
2.3.4 Merck Millipore Diagnostic Biomarkers Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Merck Millipore Recent Developments and Future Plans
2.4 Bio-Rad Laboratories, Inc.
2.4.1 Bio-Rad Laboratories, Inc. Details
2.4.2 Bio-Rad Laboratories, Inc. Major Business
2.4.3 Bio-Rad Laboratories, Inc. Diagnostic Biomarkers Product and Solutions
2.4.4 Bio-Rad Laboratories, Inc. Diagnostic Biomarkers Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Bio-Rad Laboratories, Inc. Recent Developments and Future Plans
2.5 Enzo Biochem, Inc.
2.5.1 Enzo Biochem, Inc. Details
2.5.2 Enzo Biochem, Inc. Major Business
2.5.3 Enzo Biochem, Inc. Diagnostic Biomarkers Product and Solutions
2.5.4 Enzo Biochem, Inc. Diagnostic Biomarkers Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Enzo Biochem, Inc. Recent Developments and Future Plans
2.6 EKF Diagnostics Holdings, Inc.
2.6.1 EKF Diagnostics Holdings, Inc. Details
2.6.2 EKF Diagnostics Holdings, Inc. Major Business
2.6.3 EKF Diagnostics Holdings, Inc. Diagnostic Biomarkers Product and Solutions
2.6.4 EKF Diagnostics Holdings, Inc. Diagnostic Biomarkers Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 EKF Diagnostics Holdings, Inc. Recent Developments and Future Plans
2.7 Meso Scale Diagnostics, LLC.
2.7.1 Meso Scale Diagnostics, LLC. Details
2.7.2 Meso Scale Diagnostics, LLC. Major Business
2.7.3 Meso Scale Diagnostics, LLC. Diagnostic Biomarkers Product and Solutions
2.7.4 Meso Scale Diagnostics, LLC. Diagnostic Biomarkers Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Meso Scale Diagnostics, LLC. Recent Developments and Future Plans
2.8 Biosims Technologies Sas
2.8.1 Biosims Technologies Sas Details
2.8.2 Biosims Technologies Sas Major Business
2.8.3 Biosims Technologies Sas Diagnostic Biomarkers Product and Solutions
2.8.4 Biosims Technologies Sas Diagnostic Biomarkers Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Biosims Technologies Sas Recent Developments and Future Plans
2.9 Cisbio Bioassays
2.9.1 Cisbio Bioassays Details
2.9.2 Cisbio Bioassays Major Business
2.9.3 Cisbio Bioassays Diagnostic Biomarkers Product and Solutions
2.9.4 Cisbio Bioassays Diagnostic Biomarkers Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Cisbio Bioassays Recent Developments and Future Plans
2.10 Signosis, Inc
2.10.1 Signosis, Inc Details
2.10.2 Signosis, Inc Major Business
2.10.3 Signosis, Inc Diagnostic Biomarkers Product and Solutions
2.10.4 Signosis, Inc Diagnostic Biomarkers Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Signosis, Inc Recent Developments and Future Plans
2.11 Banyan Biomarkers, Inc
2.11.1 Banyan Biomarkers, Inc Details
2.11.2 Banyan Biomarkers, Inc Major Business
2.11.3 Banyan Biomarkers, Inc Diagnostic Biomarkers Product and Solutions
2.11.4 Banyan Biomarkers, Inc Diagnostic Biomarkers Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Banyan Biomarkers, Inc Recent Developments and Future Plans
2.12 Biomedical Corp
2.12.1 Biomedical Corp Details
2.12.2 Biomedical Corp Major Business
2.12.3 Biomedical Corp Diagnostic Biomarkers Product and Solutions
2.12.4 Biomedical Corp Diagnostic Biomarkers Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Biomedical Corp Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Diagnostic Biomarkers Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Diagnostic Biomarkers Players Market Share
3.2.2 Top 10 Diagnostic Biomarkers Players Market Share
3.2.3 Market Competition Trend
3.3 Diagnostic Biomarkers Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Diagnostic Biomarkers Revenue and Market Share by Type (2016-2021)
4.2 Global Diagnostic Biomarkers Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Diagnostic Biomarkers Revenue Market Share by Application (2016-2021)
5.2 Diagnostic Biomarkers Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Diagnostic Biomarkers Revenue by Type (2016-2026)
6.2 North America Diagnostic Biomarkers Revenue by Application (2016-2026)
6.3 North America Diagnostic Biomarkers Market Size by Country
6.3.1 North America Diagnostic Biomarkers Revenue by Country (2016-2026)
6.3.2 United States Diagnostic Biomarkers Market Size and Forecast (2016-2026)
6.3.3 Canada Diagnostic Biomarkers Market Size and Forecast (2016-2026)
6.3.4 Mexico Diagnostic Biomarkers Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Diagnostic Biomarkers Revenue by Type (2016-2026)
7.2 Europe Diagnostic Biomarkers Revenue by Application (2016-2026)
7.3 Europe Diagnostic Biomarkers Market Size by Country
7.3.1 Europe Diagnostic Biomarkers Revenue by Country (2016-2026)
7.3.2 Germany Diagnostic Biomarkers Market Size and Forecast (2016-2026)
7.3.3 France Diagnostic Biomarkers Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Diagnostic Biomarkers Market Size and Forecast (2016-2026)
7.3.5 Russia Diagnostic Biomarkers Market Size and Forecast (2016-2026)
7.3.6 Italy Diagnostic Biomarkers Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Diagnostic Biomarkers Revenue by Type (2016-2026)
8.2 Asia-Pacific Diagnostic Biomarkers Revenue by Application (2016-2026)
8.3 Asia-Pacific Diagnostic Biomarkers Market Size by Region
8.3.1 Asia-Pacific Diagnostic Biomarkers Revenue by Region (2016-2026)
8.3.2 China Diagnostic Biomarkers Market Size and Forecast (2016-2026)
8.3.3 Japan Diagnostic Biomarkers Market Size and Forecast (2016-2026)
8.3.4 South Korea Diagnostic Biomarkers Market Size and Forecast (2016-2026)
8.3.5 India Diagnostic Biomarkers Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Diagnostic Biomarkers Market Size and Forecast (2016-2026)
8.3.7 Australia Diagnostic Biomarkers Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Diagnostic Biomarkers Revenue by Type (2016-2026)
9.2 South America Diagnostic Biomarkers Revenue by Application (2016-2026)
9.3 South America Diagnostic Biomarkers Market Size by Country
9.3.1 South America Diagnostic Biomarkers Revenue by Country (2016-2026)
9.3.2 Brazil Diagnostic Biomarkers Market Size and Forecast (2016-2026)
9.3.3 Argentina Diagnostic Biomarkers Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Diagnostic Biomarkers Revenue by Type (2016-2026)
10.2 Middle East & Africa Diagnostic Biomarkers Revenue by Application (2016-2026)
10.3 Middle East & Africa Diagnostic Biomarkers Market Size by Country
10.3.1 Middle East & Africa Diagnostic Biomarkers Revenue by Country (2016-2026)
10.3.2 Turkey Diagnostic Biomarkers Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Diagnostic Biomarkers Market Size and Forecast (2016-2026)
10.3.4 UAE Diagnostic Biomarkers Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Diagnostic Biomarkers Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Diagnostic Biomarkers Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Diagnostic Biomarkers Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Diagnostic Biomarkers Revenue (USD Million) by Region (2016-2021)
Table 5. Global Diagnostic Biomarkers Revenue Market Share by Region (2021-2026)
Table 6. Qiagen N.V. Corporate Information, Head Office, and Major Competitors
Table 7. Qiagen N.V. Major Business
Table 8. Qiagen N.V. Diagnostic Biomarkers Product and Solutions
Table 9. Qiagen N.V. Diagnostic Biomarkers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Perkinelmer, Inc. Corporate Information, Head Office, and Major Competitors
Table 11. Perkinelmer, Inc. Major Business
Table 12. Perkinelmer, Inc. Diagnostic Biomarkers Product and Solutions
Table 13. Perkinelmer, Inc. Diagnostic Biomarkers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Merck Millipore Corporate Information, Head Office, and Major Competitors
Table 15. Merck Millipore Major Business
Table 16. Merck Millipore Diagnostic Biomarkers Product and Solutions
Table 17. Merck Millipore Diagnostic Biomarkers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Bio-Rad Laboratories, Inc. Corporate Information, Head Office, and Major Competitors
Table 19. Bio-Rad Laboratories, Inc. Major Business
Table 20. Bio-Rad Laboratories, Inc. Diagnostic Biomarkers Product and Solutions
Table 21. Bio-Rad Laboratories, Inc. Diagnostic Biomarkers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Enzo Biochem, Inc. Corporate Information, Head Office, and Major Competitors
Table 23. Enzo Biochem, Inc. Major Business
Table 24. Enzo Biochem, Inc. Diagnostic Biomarkers Product and Solutions
Table 25. Enzo Biochem, Inc. Diagnostic Biomarkers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. EKF Diagnostics Holdings, Inc. Corporate Information, Head Office, and Major Competitors
Table 27. EKF Diagnostics Holdings, Inc. Major Business
Table 28. EKF Diagnostics Holdings, Inc. Diagnostic Biomarkers Product and Solutions
Table 29. EKF Diagnostics Holdings, Inc. Diagnostic Biomarkers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Meso Scale Diagnostics, LLC. Corporate Information, Head Office, and Major Competitors
Table 31. Meso Scale Diagnostics, LLC. Major Business
Table 32. Meso Scale Diagnostics, LLC. Diagnostic Biomarkers Product and Solutions
Table 33. Meso Scale Diagnostics, LLC. Diagnostic Biomarkers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Biosims Technologies Sas Corporate Information, Head Office, and Major Competitors
Table 35. Biosims Technologies Sas Major Business
Table 36. Biosims Technologies Sas Diagnostic Biomarkers Product and Solutions
Table 37. Biosims Technologies Sas Diagnostic Biomarkers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Cisbio Bioassays Corporate Information, Head Office, and Major Competitors
Table 39. Cisbio Bioassays Major Business
Table 40. Cisbio Bioassays Diagnostic Biomarkers Product and Solutions
Table 41. Cisbio Bioassays Diagnostic Biomarkers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Signosis, Inc Corporate Information, Head Office, and Major Competitors
Table 43. Signosis, Inc Major Business
Table 44. Signosis, Inc Diagnostic Biomarkers Product and Solutions
Table 45. Signosis, Inc Diagnostic Biomarkers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Banyan Biomarkers, Inc Corporate Information, Head Office, and Major Competitors
Table 47. Banyan Biomarkers, Inc Major Business
Table 48. Banyan Biomarkers, Inc Diagnostic Biomarkers Product and Solutions
Table 49. Banyan Biomarkers, Inc Diagnostic Biomarkers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Biomedical Corp Corporate Information, Head Office, and Major Competitors
Table 51. Biomedical Corp Major Business
Table 52. Biomedical Corp Diagnostic Biomarkers Product and Solutions
Table 53. Biomedical Corp Diagnostic Biomarkers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Global Diagnostic Biomarkers Revenue (USD Million) by Players (2019-2021)
Table 55. Global Diagnostic Biomarkers Revenue Share by Players (2019-2021)
Table 56. Breakdown of Diagnostic Biomarkers by Company Type (Tier 1, Tier 2 and Tier 3)
Table 57. Diagnostic Biomarkers Players Head Office, Products and Services Provided
Table 58. Diagnostic Biomarkers Mergers & Acquisitions in the Past Five Years
Table 59. Diagnostic Biomarkers New Entrants and Expansion Plans
Table 60. Global Diagnostic Biomarkers Revenue (USD Million) by Type (2016-2021)
Table 61. Global Diagnostic Biomarkers Revenue Share by Type (2016-2021)
Table 62. Global Diagnostic Biomarkers Revenue Forecast by Type (2021-2026)
Table 63. Global Diagnostic Biomarkers Revenue by Application (2016-2021)
Table 64. Global Diagnostic Biomarkers Revenue Forecast by Application (2021-2026)
Table 65. North America Diagnostic Biomarkers Revenue by Type (2016-2021) & (USD Million)
Table 66. North America Diagnostic Biomarkers Revenue by Type (2021-2026) & (USD Million)
Table 67. North America Diagnostic Biomarkers Revenue by Application (2016-2021) & (USD Million)
Table 68. North America Diagnostic Biomarkers Revenue by Application (2021-2026) & (USD Million)
Table 69. North America Diagnostic Biomarkers Revenue by Country (2016-2021) & (USD Million)
Table 70. North America Diagnostic Biomarkers Revenue by Country (2021-2026) & (USD Million)
Table 71. Europe Diagnostic Biomarkers Revenue by Type (2016-2021) & (USD Million)
Table 72. Europe Diagnostic Biomarkers Revenue by Type (2021-2026) & (USD Million)
Table 73. Europe Diagnostic Biomarkers Revenue by Application (2016-2021) & (USD Million)
Table 74. Europe Diagnostic Biomarkers Revenue by Application (2021-2026) & (USD Million)
Table 75. Europe Diagnostic Biomarkers Revenue by Country (2016-2021) & (USD Million)
Table 76. Europe Diagnostic Biomarkers Revenue by Country (2021-2026) & (USD Million)
Table 77. Asia-Pacific Diagnostic Biomarkers Revenue by Type (2016-2021) & (USD Million)
Table 78. Asia-Pacific Diagnostic Biomarkers Revenue by Type (2021-2026) & (USD Million)
Table 79. Asia-Pacific Diagnostic Biomarkers Revenue by Application (2016-2021) & (USD Million)
Table 80. Asia-Pacific Diagnostic Biomarkers Revenue by Application (2021-2026) & (USD Million)
Table 81. Asia-Pacific Diagnostic Biomarkers Revenue by Region (2016-2021) & (USD Million)
Table 82. Asia-Pacific Diagnostic Biomarkers Revenue by Region (2021-2026) & (USD Million)
Table 83. South America Diagnostic Biomarkers Revenue by Type (2016-2021) & (USD Million)
Table 84. South America Diagnostic Biomarkers Revenue by Type (2021-2026) & (USD Million)
Table 85. South America Diagnostic Biomarkers Revenue by Application (2016-2021) & (USD Million)
Table 86. South America Diagnostic Biomarkers Revenue by Application (2021-2026) & (USD Million)
Table 87. South America Diagnostic Biomarkers Revenue by Country (2016-2021) & (USD Million)
Table 88. South America Diagnostic Biomarkers Revenue by Country (2021-2026) & (USD Million)
Table 89. Middle East & Africa Diagnostic Biomarkers Revenue by Type (2016-2021) & (USD Million)
Table 90. Middle East & Africa Diagnostic Biomarkers Revenue by Type (2021-2026) & (USD Million)
Table 91. Middle East & Africa Diagnostic Biomarkers Revenue by Application (2016-2021) & (USD Million)
Table 92. Middle East & Africa Diagnostic Biomarkers Revenue by Application (2021-2026) & (USD Million)
Table 93. Middle East & Africa Diagnostic Biomarkers Revenue by Country (2016-2021) & (USD Million)
Table 94. Middle East & Africa Diagnostic Biomarkers Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Diagnostic Biomarkers Picture
Figure 2. Global Diagnostic Biomarkers Revenue Market Share by Type in 2020
Figure 3. Safety Biomarkers
Figure 4. Efficacy Biomarkers
Figure 5. Validation Biomarkers
Figure 6. Diagnostic Biomarkers Revenue Market Share by Application in 2020
Figure 7. Hospitals Picture
Figure 8. Cancer Research Institutes Picture
Figure 9. Diagnostic Labs Picture
Figure 10. Global Diagnostic Biomarkers Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Diagnostic Biomarkers Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Diagnostic Biomarkers Revenue Market Share by Region (2016-2026)
Figure 13. Global Diagnostic Biomarkers Revenue Market Share by Region in 2020
Figure 14. North America Diagnostic Biomarkers Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Diagnostic Biomarkers Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Diagnostic Biomarkers Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Diagnostic Biomarkers Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Diagnostic Biomarkers Market Drivers
Figure 19. Diagnostic Biomarkers Market Restraints
Figure 20. Diagnostic Biomarkers Market Trends
Figure 21. Qiagen N.V. Recent Developments and Future Plans
Figure 22. Perkinelmer, Inc. Recent Developments and Future Plans
Figure 23. Merck Millipore Recent Developments and Future Plans
Figure 24. Bio-Rad Laboratories, Inc. Recent Developments and Future Plans
Figure 25. Enzo Biochem, Inc. Recent Developments and Future Plans
Figure 26. EKF Diagnostics Holdings, Inc. Recent Developments and Future Plans
Figure 27. Meso Scale Diagnostics, LLC. Recent Developments and Future Plans
Figure 28. Biosims Technologies Sas Recent Developments and Future Plans
Figure 29. Cisbio Bioassays Recent Developments and Future Plans
Figure 30. Signosis, Inc Recent Developments and Future Plans
Figure 31. Banyan Biomarkers, Inc Recent Developments and Future Plans
Figure 32. Biomedical Corp Recent Developments and Future Plans
Figure 34. Global Diagnostic Biomarkers Revenue Share by Players in 2020
Figure 35. Diagnostic Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 36. Global Top 3 Players Diagnostic Biomarkers Revenue Market Share in 2020
Figure 37. Global Top 10 Players Diagnostic Biomarkers Revenue Market Share in 2020
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 39. Global Diagnostic Biomarkers Revenue Share by Type in 2020
Figure 40. Global Diagnostic Biomarkers Market Share Forecast by Type (2021-2026)
Figure 41. Global Diagnostic Biomarkers Revenue Share by Application in 2020
Figure 42. Global Diagnostic Biomarkers Market Share Forecast by Application (2021-2026)
Figure 43. North America Diagnostic Biomarkers Sales Market Share by Type (2016-2026)
Figure 44. North America Diagnostic Biomarkers Sales Market Share by Application (2016-2026)
Figure 45. North America Diagnostic Biomarkers Revenue Market Share by Country (2016-2026)
Figure 46. United States Diagnostic Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Canada Diagnostic Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Mexico Diagnostic Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Europe Diagnostic Biomarkers Sales Market Share by Type (2016-2026)
Figure 50. Europe Diagnostic Biomarkers Sales Market Share by Application (2016-2026)
Figure 51. Europe Diagnostic Biomarkers Revenue Market Share by Country (2016-2026)
Figure 52. Germany Diagnostic Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France Diagnostic Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom Diagnostic Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia Diagnostic Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy Diagnostic Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific Diagnostic Biomarkers Sales Market Share by Type (2016-2026)
Figure 58. Asia-Pacific Diagnostic Biomarkers Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific Diagnostic Biomarkers Revenue Market Share by Region (2016-2026)
Figure 60. China Diagnostic Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan Diagnostic Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South Korea Diagnostic Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India Diagnostic Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia Diagnostic Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia Diagnostic Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America Diagnostic Biomarkers Sales Market Share by Type (2016-2026)
Figure 67. South America Diagnostic Biomarkers Sales Market Share by Application (2016-2026)
Figure 68. South America Diagnostic Biomarkers Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Diagnostic Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Diagnostic Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East and Africa Diagnostic Biomarkers Sales Market Share by Type (2016-2026)
Figure 72. Middle East and Africa Diagnostic Biomarkers Sales Market Share by Application (2016-2026)
Figure 73. Middle East and Africa Diagnostic Biomarkers Revenue Market Share by Country (2016-2026)
Figure 74. Turkey Diagnostic Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia Diagnostic Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. UAE Diagnostic Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界の予測バイオマーカー市場規模・現状・予測（2021年-2027年） Predictive biomarkers help to optimize therapy decisions, as they provide information on the likelihood of response to a given chemotherapeutic. The predictive biomarkers market is expected to register a fast growth over the forecast period owing to the increase in the prevalence rate of cancer. Mar…- 世界のゲノミクスバイオマーカー市場規模・現状・予測（2021年-2027年） A measurable DNA and/or RNA characteristic is an indicator of normal biologic processes, pathogenic processes, and/or response to a therapeutic or other interventions. A genomic biomarker can be used for measuring the expression, function, and regulation of a gene. These biomarkers have characterist…
- 世界のEPOバイオマーカー市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global EPO Biomarkers Market The global EPO Biomarkers market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brill…
- 世界のがんバイオマーカー検出市場規模・現状・予測（2021年-2027年） Cancer markers refer to substances directly produced by tumor cells or induced by non-tumor cells through tumor cells. Market Analysis and Insights: Global Cancer Biomarkers Detection Market The global Cancer Biomarkers Detection market size is projected to reach US$ XX million by 2027, from US$ XX …
- 世界のバイオマーカー市場規模・現状・予測（2021年-2027年） In biological system, it means to calculate the whole number by marking part of individuals. North America is the largest consumption place, with a consumption market share nearly 32% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share o…